315 related articles for article (PubMed ID: 24372208)
21. Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.
He L; Yang X; Cao X; Liu F; Quan M; Cao J
Oncol Rep; 2013 Jan; 29(1):103-8. PubMed ID: 23064420
[TBL] [Abstract][Full Text] [Related]
22. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.
Paik JH; Kollipara R; Chu G; Ji H; Xiao Y; Ding Z; Miao L; Tothova Z; Horner JW; Carrasco DR; Jiang S; Gilliland DG; Chin L; Wong WH; Castrillon DH; DePinho RA
Cell; 2007 Jan; 128(2):309-23. PubMed ID: 17254969
[TBL] [Abstract][Full Text] [Related]
23. Re-evaluating the role of FOXOs in cancer.
Hornsveld M; Dansen TB; Derksen PW; Burgering BMT
Semin Cancer Biol; 2018 Jun; 50():90-100. PubMed ID: 29175105
[TBL] [Abstract][Full Text] [Related]
24. Regulation of FoxO transcription factors by acetylation and protein-protein interactions.
Daitoku H; Sakamaki J; Fukamizu A
Biochim Biophys Acta; 2011 Nov; 1813(11):1954-60. PubMed ID: 21396404
[TBL] [Abstract][Full Text] [Related]
25. FoxO transcription factors in oxidative stress response and ageing--a new fork on the way to longevity?
Sedding DG
Biol Chem; 2008 Mar; 389(3):279-83. PubMed ID: 18208360
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor genes and ROS: complex networks of interactions.
Vurusaner B; Poli G; Basaga H
Free Radic Biol Med; 2012 Jan; 52(1):7-18. PubMed ID: 22019631
[TBL] [Abstract][Full Text] [Related]
27. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.
Scheijen B; Ngo HT; Kang H; Griffin JD
Oncogene; 2004 Apr; 23(19):3338-49. PubMed ID: 14981546
[TBL] [Abstract][Full Text] [Related]
28. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
[TBL] [Abstract][Full Text] [Related]
29. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.
Vogt PK; Jiang H; Aoki M
Cell Cycle; 2005 Jul; 4(7):908-13. PubMed ID: 15917664
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a.
Queiroz EA; Fortes ZB; da Cunha MA; Barbosa AM; Khaper N; Dekker RF
Int J Biochem Cell Biol; 2015 Oct; 67():14-24. PubMed ID: 26255117
[TBL] [Abstract][Full Text] [Related]
31. Unravelling the tumor-suppressive functions of FOXO proteins.
Dansen TB; Burgering BM
Trends Cell Biol; 2008 Sep; 18(9):421-9. PubMed ID: 18715783
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms controlling the anti-neoplastic functions of FoxO proteins.
Hou T; Li Z; Zhao Y; Zhu WG
Semin Cancer Biol; 2018 Jun; 50():101-114. PubMed ID: 29155239
[TBL] [Abstract][Full Text] [Related]
33. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
34. CNK1 and other scaffolds for Akt/FoxO signaling.
Fritz RD; Radziwill G
Biochim Biophys Acta; 2011 Nov; 1813(11):1971-7. PubMed ID: 21320536
[TBL] [Abstract][Full Text] [Related]
35. Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation.
Zhou Y; Liang C; Xue F; Chen W; Zhi X; Feng X; Bai X; Liang T
Oncotarget; 2015 Apr; 6(12):10350-65. PubMed ID: 25871400
[TBL] [Abstract][Full Text] [Related]
36. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
[TBL] [Abstract][Full Text] [Related]
37. Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer.
Arden KC
Exp Gerontol; 2006 Aug; 41(8):709-17. PubMed ID: 16806782
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as master regulators of FOXO transcription factors in cancer management.
Rani M; Kumari R; Singh SP; Devi A; Bansal P; Siddiqi A; Alsahli MA; Almatroodi SA; Rahmani AH; Rizvi MMA
Life Sci; 2023 May; 321():121535. PubMed ID: 36906255
[TBL] [Abstract][Full Text] [Related]
39. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
40. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
